1. Zhu, Min, Tao, Yu, He, Qin, Wu, Zhi-Ying, Saffen, David. 2014. Common GSAP promoter variant contributes to Alzheimer's disease liability. In Neurobiology of aging, 35, 2656.e1-2656.e7. doi:10.1016/j.neurobiolaging.2014.05.018. https://pubmed.ncbi.nlm.nih.gov/25037285/
2. Wong, Eitan, Liao, George P, Chang, Jerry C, Li, Yue-Ming, Greengard, Paul. 2019. GSAP modulates γ-secretase specificity by inducing conformational change in PS1. In Proceedings of the National Academy of Sciences of the United States of America, 116, 6385-6390. doi:10.1073/pnas.1820160116. https://pubmed.ncbi.nlm.nih.gov/30850537/
3. Hajjari, Seyedeh Nazanin, Sadigh-Eteghad, Saeed, Shanehbandi, Dariush, Shahbazi, Ali, Mehdizadeh, Mehdi. 2021. MicroRNA-4422-5p as a Negative Regulator of Amyloidogenic Secretases: A Potential Biomarker for Alzheimer's Disease. In Neuroscience, 463, 108-115. doi:10.1016/j.neuroscience.2021.03.028. https://pubmed.ncbi.nlm.nih.gov/33836245/
4. Chu, Jin, Li, Jian-Guo, Joshi, Yash B, Madesh, Muniswamy, Praticò, Domenico. 2014. Gamma secretase-activating protein is a substrate for caspase-3: implications for Alzheimer's disease. In Biological psychiatry, 77, 720-8. doi:10.1016/j.biopsych.2014.06.003. https://pubmed.ncbi.nlm.nih.gov/25052851/
5. Kim, Sunghwa, Ullah, Irfan, Beloor, Jagadish, Kumar, Priti, Lee, Sang-Kyung. 2024. Systemic Treatment with siRNA Targeting Gamma-Secretase Activating Protein Inhibits Amyloid-β Accumulation in Alzheimer's Disease. In Biomaterials research, 28, 0027. doi:10.34133/bmr.0027. https://pubmed.ncbi.nlm.nih.gov/38868092/
6. Deng, Hui, Xu, Honglan, Luo, Yuxuan. 2022. Mechanisms of miR-29a-5p involvement in osteogenic phenotype transformation and cellular regulation of vascular smooth muscle and thus influencing calcification in VSMCs in chronic kidney disease. In Cellular and molecular biology (Noisy-le-Grand, France), 68, 123-128. doi:10.14715/cmb/2022.68.7.20. https://pubmed.ncbi.nlm.nih.gov/36495508/
7. He, Gen, Luo, Wenjie, Li, Peng, Wennogle, Lawrence P, Greengard, Paul. . Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease. In Nature, 467, 95-8. doi:10.1038/nature09325. https://pubmed.ncbi.nlm.nih.gov/20811458/
智鼠故事 
